The managed care industry is at a crossroads. Belief in the ability of mark
et forces alone to create an environment fostering quality health care at l
ower cost is eroding. Regulators across the country are confronted with a g
rowing consumer backlash against managed care. As a result, states have pas
sed managed care reform legislation at unprecedented rates. In doing so, st
ates are confronted with a patchwork of federal intervention and preemption
. We examine the stages of these recent state and federal developments and
evaluate them in terms of the traditional objectives of a reasonably functi
oning health care system: quality care, access, and cost containment.